• Tentarix Bio unveils $50M for biologics with multiple functions, multiple targets

    12 days ago - By MedCity News

    Biotech startup Tentarix Biotherapeutics has come out of stealth with $50 million and technology that develops biologic drugs endowed with multiple functions. The company aims to develop new multispecific biologic drugs for cancer and autoimmune diseases.
    Read more ...